4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-017307
President sold 15,000 shares at an average $58.32 ($874,743)
- President acquired 15,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| RUBINSTEIN JULIE President | 2021-03-01 | Option exercise | +15,000 | $6.55 | $98,250 | 15,000 | D: show line 1 in the form |
| RUBINSTEIN JULIE President | 2021-03-01 | Sale | −4,684 | $57.54 | $269,517 | 10,316 | D: show line 2 in the form |
| RUBINSTEIN JULIE President | 2021-03-01 | Sale | −9,471 | $58.64 | $555,379 | 845 | D: show line 3 in the form |
| RUBINSTEIN JULIE President | 2021-03-01 | Sale | −845 | $58.99 | $49,847 | 0 | D: show line 4 in the form |
| Open-market sales · 15,000 sh · avg $58.32 · $874,743 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| RUBINSTEIN JULIE President | 2021-03-01 | Option exercise · Stock Option (Right to Buy) | −15,000 | 225,325 | D: show line 5 in the form |
Loading xslF345X03/doc4.xml…